PreSens Recognized as a Key Innovator by the European Union
February 13, 2025PreSens Precision Sensing GmbH has been acknowledged as a "Key Innovator" by the European Commission for its groundbreaking innovation developed under the EU-funded SCREENED project.
The innovation, titled "Biosensors for 3D cell culture to monitor analytes in tissue/3D constructs, bioreactors, and implants", has been published on the European Innovation Radar's public website, showcasing PreSens' commitment to cutting-edge research and technological advancement. This achievement highlights PreSens’ leadership in creating state-of-the-art biosensing solutions that push the boundaries of tissue engineering and regenerative medicine. By integrating advanced biosensors into 3D cell culture systems, PreSens offers unparalleled tools for real-time monitoring of key analytes, driving progress in biomedical research and clinical applications.
This innovation was developed under the Horizon 2020 project SCREENED with an end date of 30/06/2024
